This protocol was contributed by a third party and has not been verified. Provided for informational and standards-development purposes only — see the Disclaimer & Terms of Use.

CDISC PILOT - LZZT

Status & Metadata
Source Method : Publicly Available
Source URL: Link
Generation Method : Unknown
Date Added: 16 Jun 2026
Contributor: System
View USDM Protocol Download JSON
Additional Resources
CDISC CORE Conformance
Conformance assessed
SUCCESS 193
SKIPPED 12
EXECUTION_ERROR 2
Download Excel report Download JSON report

Rationale

The discontinuation rate associated with this oral dosing regimen was 58.6% in previous studies, and alternative clinical strategies have been sought to improve tolerance for the compound. To that end, development of a Transdermal Therapeutic System (TTS) has been initiated.

Key Metrics

Interventional Study
Phase II Trial
2
N/A

Important Dates

Event Date
Design Approval 01 Jun 2006

Schedule of Activities: Study Design 1

Timeline: Main Timeline
Visit / Timing Interval Window Activities
Screening
TIM1 		2 weeks No window
  • Vital Signs and Temperature
  • Study drug record , Medications dispensed, Medications returned
Pre dose
TIM2 		2 days -4..0 hours
  • Vital Signs and Temperature
  • Study drug record , Medications dispensed, Medications returned
Dosing
TIM3 		1 Day No window
  • Vital Signs and Temperature
  • Study drug record , Medications dispensed, Medications returned
Week 2
TIM4 		2 Weeks -3..3 days
  • Vital Signs and Temperature
  • Study drug record , Medications dispensed, Medications returned
Week 4
TIM5 		4 Weeks -3..3 days
  • Vital Signs and Temperature
  • Study drug record , Medications dispensed, Medications returned
Week 6
TIM6 		6 Weeks -3..3 days
  • Vital Signs and Temperature
  • Study drug record , Medications dispensed, Medications returned
Week 8
TIM7 		8 Weeks -3..3 days
  • Vital Signs and Temperature
  • Study drug record , Medications dispensed, Medications returned
Week 12
TIM9 		12 Weeks -4..4 days
  • Vital Signs and Temperature
  • Study drug record , Medications dispensed, Medications returned
Week 16
TIM11 		16 Weeks -4..4 days
  • Vital Signs and Temperature
  • Study drug record , Medications dispensed, Medications returned
Week 20
TIM13 		20 Weeks -4..4 days
  • Vital Signs and Temperature
  • Study drug record , Medications dispensed, Medications returned
Week 24
TIM15 		24 Weeks -4..4 days
  • Vital Signs and Temperature
  • Study drug record , Medications dispensed, Medications returned
Week 26
TIM16 		26 Weeks -3..3 days
  • Vital Signs and Temperature
  • Study drug record , Medications dispensed, Medications returned
Week 8 Home
TIM8 		2 Weeks No window
  • Vital Signs and Temperature
  • Study drug record , Medications dispensed, Medications returned
Week 12 Home
TIM10 		2 Weeks No window
  • Vital Signs and Temperature
  • Study drug record , Medications dispensed, Medications returned
Week 16 Home
TIM12 		2 Weeks No window
  • Vital Signs and Temperature
  • Study drug record , Medications dispensed, Medications returned
Week 20 Home
TIM14 		2 Weeks No window
  • Vital Signs and Temperature
  • Study drug record , Medications dispensed, Medications returned
Timeline: Adverse Event Timeline
Visit / Timing Interval Window Activities
Adverse Event
TIM17 		1 Day No window
Timeline: Early Termination Timeline
Visit / Timing Interval Window Activities
Early Termination
TIM18 		1 Day No window
  • Vital Signs and Temperature
  • Study drug record , Medications dispensed, Medications returned
Timeline: Vital Sign Blood Pressure Timeline
Visit / Timing Interval Window Activities
BP Anchor
TIM19 		0 mins No window
  • Supine for 5 minutes
BP while Supine
TIM20 		5 mins No window
  • Supine for 5 minutes
BP Stand Up
TIM21 		3 mins -2..0 min
  • Blood pressure supine
BP while standing
TIM22 		0 mins No window
  • Stand for 3 minutes